Snapshot
- A 65-year-old man with atrial fibrillation presents to his primary care physician for a rash. He reports that he recently switched antiarrhythmic medications as instructed by his cardiologist. He reports to having discoloration of his skin and a burning sensation after sun exposure. On physical exam, there are blue and gray discolorations of his skin. An eye exam also reveals yellow-brown granules in the cornea. He was discontinued from the new anti-arrhythmic medication. (Amiodarone photosensitivity)
Introduction
- Anti-arrhythmic medications are divided into 4 classes
- Class I drugs are Na+ channel blockers
- Class II drugs are β-blockers
- Class III drugs are K+ channel blockers
- Class IV drugs are Ca2+ channel blockers
Class I – Na+ Channel Blockers
- These drugs slow down conduction and ↓ slope of phase 0 depolarization
- Class IA (disopyramide, quinidine, and procainamide)
- clinical use
- atrial and ventricular arrhythmias
- re-entrant and ectopic supraventricular tachycardias (SVTs) and ventricular tachycardias (VTs)
- atrial and ventricular arrhythmias
- clinical use
- Class IB (lidocaine and mexiletine)
- clinical use
- post-myocardial infarction and other ventricular arrhythmias
- digitalis-induced arrhythmias
- clinical use
- Class IC (flecainide and propafenone)
- clinical use
- SVTs, including atrial fibrillation
- toxicity
- proarrhythmic
- clinical use
- contraindicated in structural and ischemic heart disease, especially post-myocardial infarction
Class II – β-Blockers
- Clinical use
- SVTs, including atrial fibrillation and atrial flutter
- Toxicity
- impotence
- exacerbation of lung disease (chronic obstructive pulmonary disease and asthma)
- cardiovascular effects
- bradycardia
- atrioventricular block
- heart failure
- central nervous system effects
- sedation
- sleep disturbance
- dyslipidemia (metoprolol)
- exacerbate Prinzmetal angina (propranolol)
- Treatment for an overdose of β-blockers
- saline
- atropine
- glucagon
Class III – K+ Channel Blockers
- Clinical use
- atrial fibrillation
- atrial flutter
- VT
- especially amiodarone and sotalol
- Toxicity
- amiodarone
- check pulmonary function tests (PFTs), liver function tests (LFTs), and thyroid function tests (TFTs)
- hepatotoxicity
- thyrotoxicity
- blue/gray skin deposits and photodermatitis
- corneal deposits
- neurologic effects
- gastrointestinal effects
- cardiovascular depression
- bradycardia
- heart block
- check pulmonary function tests (PFTs), liver function tests (LFTs), and thyroid function tests (TFTs)
- amiodarone
- heart failure
Class IV – Ca2+ Channel Blockers
- Clinical use
- atrial fibrillation
- prevention of SVT
- Toxicity
- constipation
- flushing
- edema
- sinus node depression
Other Anti-Arrhythmics
- Adenosine
- mechanism
- ↑ K+ out of cells causes hyperpolarization of the cell and decreased atrioventricular node conduction
- very short-acting (approximately 15 seconds)
- clinical use
- diagnosing and/or terminating SVT
- toxicity
- flushing
- hypotension
- chest pain
- sense of impending doom
- bronchospasm
- mechanism
- Mg2+
- clinical use
- torsades de pointes
- digoxin toxicity
- toxicity
- lethargy
- clinical use
- bradycardia